Biotechnology: Although financing for biotech companies is improving, it still remains tough. In the first half of 2009, funds raised by biotechnology and specialty pharmaceutical firms increased 41% to $8.3 million, excluding revenue from partnerships. Compared to the first half of 2007, financing was down 55%. Money raised through public offerings and alternative financing rose […]
The total number of pharmaceutical licensing agreements completed between June 2008 and July 2009 declined 17% year over year to 661, according to EvaluatePharma. Oncology remained the top therapeutic area for licensing agreements, with 132 deals, down 18% from the previous year. Compared to previous periods, more oncology deals focused on earlier stages. The number […]
Primary energy consumption rose 1.4% in 2008 for the slowest growth since 2001, according to the BP Statistical Review of World Energy. Non-OECD nations were responsible for most of the demand, as Asia-Pacific represented 87% of this growth, with China’s energy consumption up 7.2%. Globally, oil production increased 0.4% to 380,000 barrels per day (b/d), […]
Novartis AG has become the first company to develop a genetic test for a drug’s potential side effects. The test is part of a plan by the company to resubmit Prexige pain drug for FDA approval. Due to the high rate of liver damage associated with Prexige’s use, in 2007 the FDA rejected the drug’s […]
PricewaterhouseCoopers reports that revenues for the 40 largest mining companies (with market capitalization of $2.3 billion or more) increased 23% in 2008 to $349 billion. However, operating expenses grew 27% to $208 billion and net profit declined 14% to $57 billion. Capital expenditures increased 38% to $66 billion. The sharp decline in metal prices in […]
Tests for the rapid diagnosis of swine flu have a high failure rate, according to a study in The Journal of Clinical Virology and a soon-to-be-released study from the Centers for Diseases Control and Prevention. The manufacturers of these tests include Quidel, Inverness Medical Innovations, 3M, Thermo Fisher Scientific, Meridian Bioscience, and Becton, Dickinson. The […]
According to a survey and analysis by the Organization for Economic Co-operation and Development (OECD), investment in innovation and long-term growth is a priority of OECD nations’ economic stimulus packages. Such investments can be grouped into five themes: infrastructure improvements; R&D, science and innovation support; education and human-capital investments; investment and promotion of green technologies; […]
Several prestigious US universities are cutting back on expenses following endowment losses. University endowments declined 24% in the second half of 2008, according to the Commonfund Institute. The endowment for Harvard University, the richest US university, contributed 35% of the school’s annual revenue last fiscal year, but lost 30% of its value in fiscal 2009. […]
Despite lower earnings last year for US, European and Asian chemical companies, R&D spending increased and capital spending was mixed. Total aggregated capital spending in 2008 among the 21 US chemical firms tracked by Chemical & Engineering News increased 18.6% to $10,782 million. Last year, R&D spending for these 21 chemical companies increased 6.0% to […]
The National Institutes of Health (NIH) released its new guidelines for stem cell research earlier this month. The guidelines make available more than 700 stem cell lines for research, compared to the 20 lines previously available. In 2008, $88 million of the NIH’s $938 million budget for stem cell research went to research using human […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

